CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,017 Cr | ₹853 Cr | ₹71 Cr | ₹617 Cr | ₹5,123 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,017 Cr |
| Mar2024 | ₹853 Cr |
| Mar2023 | ₹71 Cr |
| Mar2022 | ₹617 Cr |
| Mar2021 | ₹5,123 Cr |
How is Revenue of CONCORD BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,017 Cr | 19.20 | |
| Mar2024 | ₹853 Cr | 1,096.71 | |
| Mar2023 | ₹71 Cr | -88.44 | |
| Mar2022 | ₹617 Cr | -87.96 | |
| Mar2021 | ₹5,123 Cr | - | |
Compare Revenue of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,813.5 Cr | -8.5% | -7.7% | -33.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -8.5% |
-7.7% |
-33.9% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses